Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis

Tumors with papillary cribriform and morular architecture were initially considered to be variants of papillary thyroid carcinoma; however, recent observations have challenged this view. In this study, we reviewed the demographical, histopathological, and immunohistochemical features of the largest...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrine pathology 2021-09, Vol.32 (3), p.327-335
Hauptverfasser: Boyraz, Baris, Sadow, Peter M., Asa, Sylvia L., Dias-Santagata, Dora, Nosé, Vania, Mete, Ozgur
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 335
container_issue 3
container_start_page 327
container_title Endocrine pathology
container_volume 32
creator Boyraz, Baris
Sadow, Peter M.
Asa, Sylvia L.
Dias-Santagata, Dora
Nosé, Vania
Mete, Ozgur
description Tumors with papillary cribriform and morular architecture were initially considered to be variants of papillary thyroid carcinoma; however, recent observations have challenged this view. In this study, we reviewed the demographical, histopathological, and immunohistochemical features of the largest case series, consisting of 33 tumors. The age at time of pathological diagnosis ranged from 18 to 59 (mean 33) years, and all patients except one were female. Sixteen patients had multifocal and fifteen had unifocal disease. The status of focality was unavailable in two patients. Tumors were well-circumscribed, ranging in size from 0.1 to 8.0 cm. The cribriform component was admixed with morulae in the majority, except seven had a cribriform-predominant architecture and two had predominantly solid growth. Variable degrees of nuclear enlargement, elongation, overlapping, and grooves were seen but florid nuclear convolution, intranuclear pseudoinclusions, and optically clear nuclei due to chromatin margination were not appreciated. There was no or little colloid material within the cribriform spaces. Two solid tumors had high-grade features. Immunohistochemical studies showed beta-catenin nuclear and cytoplasmic positivity in all cases. The cribriform component was positive for TTF1 and negative for thyroglobulin. PAX8 was absent in half of these tumors and focal in the remainder. Morulae were positive for keratin 5 and CD5 and negative for p63, p40, TTF1, and PAX8. Molecular studies revealed germline APC mutations in 12 tumors and were negative in 5 sporadic tumors in a subset of tested tumors. Irrespective of the antibody used in this cohort, all cribriform-morular carcinomas express TTF1; however, PAX8 immunoreactivity is weak, focal or negative, and all tumors lack thyroglobulin reactivity; these findings raise questions about tumor cell origin and may indicate that these are not of thyroid follicular epithelial differentiation. We postulate that morulae may represent divergent thymic/ultimobranchial pouch-related differentiation. Given their unique cytomorphology, immunohistochemical profiles, and genetic features that have little overlap with traditional follicular cell-derived thyroid carcinomas, we propose that these tumors represent a distinct form of thyroid carcinoma unrelated to other neoplasms of thyroid follicular cells.
doi_str_mv 10.1007/s12022-021-09683-0
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9353615</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2562078016</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-563e26baffbb4c6df6061c5c4d1f9fa848a83dfa705b0cc7b0a6e74189873dcf3</originalsourceid><addsrcrecordid>eNp9kc1u1TAQhS0Eoj_wAixQJDZsDGM7sZMNEgoUKrXqpt1iTRz71lViFztBum-Pyy0X2kVXY-l8c2bGh5A3DD4wAPUxMw6cU-CMQidbQeEZOWRN01GATj0vb6glFZ2SB-Qo5xsAJgD4S3IgamAdF_KQ_OiTH5J3Mc30PKZ1wlRdXm9T9GPVYzI-xBmr01xh9cXnxQez7PVznPwmYDDbKrrqKhibFvSh6rdL3Nhgs8-vyAuHU7av7-sxuTr5etl_p2cX3077z2fU1KpeaCOF5XJA54ahNnJ0EiQzjalH5jqHbd1iK0aHCpoBjFEDoLSqZm3XKjEaJ47Jp53v7TrMdjQ2LAknfZv8jGmrI3r9UAn-Wm_iL92JRkjWFIP39wYp_lxtXvTss7HThMHGNWveCMbLd6s79N0j9CauKZTzCiU5qBaYLBTfUSbFnJN1-2UY6Lv49C4-XeLTf-LTUJre_n_GvuVvXgUQOyAXKWxs-jf7CdvfxRCnaQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2562078016</pqid></control><display><type>article</type><title>Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Boyraz, Baris ; Sadow, Peter M. ; Asa, Sylvia L. ; Dias-Santagata, Dora ; Nosé, Vania ; Mete, Ozgur</creator><creatorcontrib>Boyraz, Baris ; Sadow, Peter M. ; Asa, Sylvia L. ; Dias-Santagata, Dora ; Nosé, Vania ; Mete, Ozgur</creatorcontrib><description>Tumors with papillary cribriform and morular architecture were initially considered to be variants of papillary thyroid carcinoma; however, recent observations have challenged this view. In this study, we reviewed the demographical, histopathological, and immunohistochemical features of the largest case series, consisting of 33 tumors. The age at time of pathological diagnosis ranged from 18 to 59 (mean 33) years, and all patients except one were female. Sixteen patients had multifocal and fifteen had unifocal disease. The status of focality was unavailable in two patients. Tumors were well-circumscribed, ranging in size from 0.1 to 8.0 cm. The cribriform component was admixed with morulae in the majority, except seven had a cribriform-predominant architecture and two had predominantly solid growth. Variable degrees of nuclear enlargement, elongation, overlapping, and grooves were seen but florid nuclear convolution, intranuclear pseudoinclusions, and optically clear nuclei due to chromatin margination were not appreciated. There was no or little colloid material within the cribriform spaces. Two solid tumors had high-grade features. Immunohistochemical studies showed beta-catenin nuclear and cytoplasmic positivity in all cases. The cribriform component was positive for TTF1 and negative for thyroglobulin. PAX8 was absent in half of these tumors and focal in the remainder. Morulae were positive for keratin 5 and CD5 and negative for p63, p40, TTF1, and PAX8. Molecular studies revealed germline APC mutations in 12 tumors and were negative in 5 sporadic tumors in a subset of tested tumors. Irrespective of the antibody used in this cohort, all cribriform-morular carcinomas express TTF1; however, PAX8 immunoreactivity is weak, focal or negative, and all tumors lack thyroglobulin reactivity; these findings raise questions about tumor cell origin and may indicate that these are not of thyroid follicular epithelial differentiation. We postulate that morulae may represent divergent thymic/ultimobranchial pouch-related differentiation. Given their unique cytomorphology, immunohistochemical profiles, and genetic features that have little overlap with traditional follicular cell-derived thyroid carcinomas, we propose that these tumors represent a distinct form of thyroid carcinoma unrelated to other neoplasms of thyroid follicular cells.</description><identifier>ISSN: 1046-3976</identifier><identifier>EISSN: 1559-0097</identifier><identifier>DOI: 10.1007/s12022-021-09683-0</identifier><identifier>PMID: 34019236</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adenocarcinoma - pathology ; Adenomatous polyposis coli ; Adolescent ; Adult ; CD5 antigen ; Chromatin ; Endocrinology ; Female ; Humans ; Immunoreactivity ; Keratin ; Male ; Malignancy ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Neoplasia ; Oncology ; Papillary thyroid carcinoma ; Pathology ; Pax8 protein ; Solid tumors ; Thymus ; Thyrocytes ; Thyroglobulin ; Thyroid ; Thyroid cancer ; Thyroid Neoplasms - pathology ; Tumors ; Young Adult ; β-Catenin</subject><ispartof>Endocrine pathology, 2021-09, Vol.32 (3), p.327-335</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-563e26baffbb4c6df6061c5c4d1f9fa848a83dfa705b0cc7b0a6e74189873dcf3</citedby><cites>FETCH-LOGICAL-c474t-563e26baffbb4c6df6061c5c4d1f9fa848a83dfa705b0cc7b0a6e74189873dcf3</cites><orcidid>0000-0003-0469-2801</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12022-021-09683-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12022-021-09683-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34019236$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boyraz, Baris</creatorcontrib><creatorcontrib>Sadow, Peter M.</creatorcontrib><creatorcontrib>Asa, Sylvia L.</creatorcontrib><creatorcontrib>Dias-Santagata, Dora</creatorcontrib><creatorcontrib>Nosé, Vania</creatorcontrib><creatorcontrib>Mete, Ozgur</creatorcontrib><title>Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis</title><title>Endocrine pathology</title><addtitle>Endocr Pathol</addtitle><addtitle>Endocr Pathol</addtitle><description>Tumors with papillary cribriform and morular architecture were initially considered to be variants of papillary thyroid carcinoma; however, recent observations have challenged this view. In this study, we reviewed the demographical, histopathological, and immunohistochemical features of the largest case series, consisting of 33 tumors. The age at time of pathological diagnosis ranged from 18 to 59 (mean 33) years, and all patients except one were female. Sixteen patients had multifocal and fifteen had unifocal disease. The status of focality was unavailable in two patients. Tumors were well-circumscribed, ranging in size from 0.1 to 8.0 cm. The cribriform component was admixed with morulae in the majority, except seven had a cribriform-predominant architecture and two had predominantly solid growth. Variable degrees of nuclear enlargement, elongation, overlapping, and grooves were seen but florid nuclear convolution, intranuclear pseudoinclusions, and optically clear nuclei due to chromatin margination were not appreciated. There was no or little colloid material within the cribriform spaces. Two solid tumors had high-grade features. Immunohistochemical studies showed beta-catenin nuclear and cytoplasmic positivity in all cases. The cribriform component was positive for TTF1 and negative for thyroglobulin. PAX8 was absent in half of these tumors and focal in the remainder. Morulae were positive for keratin 5 and CD5 and negative for p63, p40, TTF1, and PAX8. Molecular studies revealed germline APC mutations in 12 tumors and were negative in 5 sporadic tumors in a subset of tested tumors. Irrespective of the antibody used in this cohort, all cribriform-morular carcinomas express TTF1; however, PAX8 immunoreactivity is weak, focal or negative, and all tumors lack thyroglobulin reactivity; these findings raise questions about tumor cell origin and may indicate that these are not of thyroid follicular epithelial differentiation. We postulate that morulae may represent divergent thymic/ultimobranchial pouch-related differentiation. Given their unique cytomorphology, immunohistochemical profiles, and genetic features that have little overlap with traditional follicular cell-derived thyroid carcinomas, we propose that these tumors represent a distinct form of thyroid carcinoma unrelated to other neoplasms of thyroid follicular cells.</description><subject>Adenocarcinoma - pathology</subject><subject>Adenomatous polyposis coli</subject><subject>Adolescent</subject><subject>Adult</subject><subject>CD5 antigen</subject><subject>Chromatin</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoreactivity</subject><subject>Keratin</subject><subject>Male</subject><subject>Malignancy</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Neoplasia</subject><subject>Oncology</subject><subject>Papillary thyroid carcinoma</subject><subject>Pathology</subject><subject>Pax8 protein</subject><subject>Solid tumors</subject><subject>Thymus</subject><subject>Thyrocytes</subject><subject>Thyroglobulin</subject><subject>Thyroid</subject><subject>Thyroid cancer</subject><subject>Thyroid Neoplasms - pathology</subject><subject>Tumors</subject><subject>Young Adult</subject><subject>β-Catenin</subject><issn>1046-3976</issn><issn>1559-0097</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kc1u1TAQhS0Eoj_wAixQJDZsDGM7sZMNEgoUKrXqpt1iTRz71lViFztBum-Pyy0X2kVXY-l8c2bGh5A3DD4wAPUxMw6cU-CMQidbQeEZOWRN01GATj0vb6glFZ2SB-Qo5xsAJgD4S3IgamAdF_KQ_OiTH5J3Mc30PKZ1wlRdXm9T9GPVYzI-xBmr01xh9cXnxQez7PVznPwmYDDbKrrqKhibFvSh6rdL3Nhgs8-vyAuHU7av7-sxuTr5etl_p2cX3077z2fU1KpeaCOF5XJA54ahNnJ0EiQzjalH5jqHbd1iK0aHCpoBjFEDoLSqZm3XKjEaJ47Jp53v7TrMdjQ2LAknfZv8jGmrI3r9UAn-Wm_iL92JRkjWFIP39wYp_lxtXvTss7HThMHGNWveCMbLd6s79N0j9CauKZTzCiU5qBaYLBTfUSbFnJN1-2UY6Lv49C4-XeLTf-LTUJre_n_GvuVvXgUQOyAXKWxs-jf7CdvfxRCnaQ</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Boyraz, Baris</creator><creator>Sadow, Peter M.</creator><creator>Asa, Sylvia L.</creator><creator>Dias-Santagata, Dora</creator><creator>Nosé, Vania</creator><creator>Mete, Ozgur</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0469-2801</orcidid></search><sort><creationdate>20210901</creationdate><title>Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis</title><author>Boyraz, Baris ; Sadow, Peter M. ; Asa, Sylvia L. ; Dias-Santagata, Dora ; Nosé, Vania ; Mete, Ozgur</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-563e26baffbb4c6df6061c5c4d1f9fa848a83dfa705b0cc7b0a6e74189873dcf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adenocarcinoma - pathology</topic><topic>Adenomatous polyposis coli</topic><topic>Adolescent</topic><topic>Adult</topic><topic>CD5 antigen</topic><topic>Chromatin</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoreactivity</topic><topic>Keratin</topic><topic>Male</topic><topic>Malignancy</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Neoplasia</topic><topic>Oncology</topic><topic>Papillary thyroid carcinoma</topic><topic>Pathology</topic><topic>Pax8 protein</topic><topic>Solid tumors</topic><topic>Thymus</topic><topic>Thyrocytes</topic><topic>Thyroglobulin</topic><topic>Thyroid</topic><topic>Thyroid cancer</topic><topic>Thyroid Neoplasms - pathology</topic><topic>Tumors</topic><topic>Young Adult</topic><topic>β-Catenin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boyraz, Baris</creatorcontrib><creatorcontrib>Sadow, Peter M.</creatorcontrib><creatorcontrib>Asa, Sylvia L.</creatorcontrib><creatorcontrib>Dias-Santagata, Dora</creatorcontrib><creatorcontrib>Nosé, Vania</creatorcontrib><creatorcontrib>Mete, Ozgur</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Endocrine pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boyraz, Baris</au><au>Sadow, Peter M.</au><au>Asa, Sylvia L.</au><au>Dias-Santagata, Dora</au><au>Nosé, Vania</au><au>Mete, Ozgur</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis</atitle><jtitle>Endocrine pathology</jtitle><stitle>Endocr Pathol</stitle><addtitle>Endocr Pathol</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>32</volume><issue>3</issue><spage>327</spage><epage>335</epage><pages>327-335</pages><issn>1046-3976</issn><eissn>1559-0097</eissn><abstract>Tumors with papillary cribriform and morular architecture were initially considered to be variants of papillary thyroid carcinoma; however, recent observations have challenged this view. In this study, we reviewed the demographical, histopathological, and immunohistochemical features of the largest case series, consisting of 33 tumors. The age at time of pathological diagnosis ranged from 18 to 59 (mean 33) years, and all patients except one were female. Sixteen patients had multifocal and fifteen had unifocal disease. The status of focality was unavailable in two patients. Tumors were well-circumscribed, ranging in size from 0.1 to 8.0 cm. The cribriform component was admixed with morulae in the majority, except seven had a cribriform-predominant architecture and two had predominantly solid growth. Variable degrees of nuclear enlargement, elongation, overlapping, and grooves were seen but florid nuclear convolution, intranuclear pseudoinclusions, and optically clear nuclei due to chromatin margination were not appreciated. There was no or little colloid material within the cribriform spaces. Two solid tumors had high-grade features. Immunohistochemical studies showed beta-catenin nuclear and cytoplasmic positivity in all cases. The cribriform component was positive for TTF1 and negative for thyroglobulin. PAX8 was absent in half of these tumors and focal in the remainder. Morulae were positive for keratin 5 and CD5 and negative for p63, p40, TTF1, and PAX8. Molecular studies revealed germline APC mutations in 12 tumors and were negative in 5 sporadic tumors in a subset of tested tumors. Irrespective of the antibody used in this cohort, all cribriform-morular carcinomas express TTF1; however, PAX8 immunoreactivity is weak, focal or negative, and all tumors lack thyroglobulin reactivity; these findings raise questions about tumor cell origin and may indicate that these are not of thyroid follicular epithelial differentiation. We postulate that morulae may represent divergent thymic/ultimobranchial pouch-related differentiation. Given their unique cytomorphology, immunohistochemical profiles, and genetic features that have little overlap with traditional follicular cell-derived thyroid carcinomas, we propose that these tumors represent a distinct form of thyroid carcinoma unrelated to other neoplasms of thyroid follicular cells.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>34019236</pmid><doi>10.1007/s12022-021-09683-0</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-0469-2801</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1046-3976
ispartof Endocrine pathology, 2021-09, Vol.32 (3), p.327-335
issn 1046-3976
1559-0097
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9353615
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adenocarcinoma - pathology
Adenomatous polyposis coli
Adolescent
Adult
CD5 antigen
Chromatin
Endocrinology
Female
Humans
Immunoreactivity
Keratin
Male
Malignancy
Medicine
Medicine & Public Health
Middle Aged
Neoplasia
Oncology
Papillary thyroid carcinoma
Pathology
Pax8 protein
Solid tumors
Thymus
Thyrocytes
Thyroglobulin
Thyroid
Thyroid cancer
Thyroid Neoplasms - pathology
Tumors
Young Adult
β-Catenin
title Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A55%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cribriform-Morular%20Thyroid%20Carcinoma%20Is%20a%20Distinct%20Thyroid%20Malignancy%20of%20Uncertain%20Cytogenesis&rft.jtitle=Endocrine%20pathology&rft.au=Boyraz,%20Baris&rft.date=2021-09-01&rft.volume=32&rft.issue=3&rft.spage=327&rft.epage=335&rft.pages=327-335&rft.issn=1046-3976&rft.eissn=1559-0097&rft_id=info:doi/10.1007/s12022-021-09683-0&rft_dat=%3Cproquest_pubme%3E2562078016%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2562078016&rft_id=info:pmid/34019236&rfr_iscdi=true